DK0975235T3 - Ernæringssammensætninger indeholdende oligosaccharider - Google Patents

Ernæringssammensætninger indeholdende oligosaccharider

Info

Publication number: DK0975235T3
Authority: DK; Denmark
Prior art keywords: lacto; compositions containing; nutritional compositions; containing oligosaccharides; fucopentaose
Prior art date: 1997-03-31

Application number

DK98912118T

Other languages

English (en)

Other versions

DK0975235T4 (da

Inventor

Pedro A Prieto

Stephen J Kirchner

Renee M Erney

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-31

Filing date

1998-03-30

Publication date

2006-10-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25253688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0975235(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-03-30 Application filed by Abbott Lab filed Critical Abbott Lab

2006-10-02 Publication of DK0975235T3 publication Critical patent/DK0975235T3/da

2014-03-31 Application granted granted Critical

2014-03-31 Publication of DK0975235T4 publication Critical patent/DK0975235T4/da

Links

239000000203 mixture Substances 0.000 title abstract 2
235000016709 nutrition Nutrition 0.000 title abstract 2
229920001542 oligosaccharide Polymers 0.000 title abstract 2
150000002482 oligosaccharides Chemical class 0.000 title abstract 2
229940062827 2'-fucosyllactose Drugs 0.000 abstract 1
HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 abstract 1
HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 abstract 1
AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 abstract 1
WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 abstract 1
TVVLIFCVJJSLBL-SEHWTJTBSA-N Lacto-N-fucopentaose V Chemical compound O[C@H]1C(O)C(O)[C@H](C)O[C@H]1OC([C@@H](O)C=O)[C@@H](C(O)CO)O[C@H]1[C@H](O)[C@@H](OC2[C@@H](C(OC3[C@@H](C(O)C(O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)O1 TVVLIFCVJJSLBL-SEHWTJTBSA-N 0.000 abstract 1
LKOHREGGXUJGKC-UHFFFAOYSA-N Lactodifucotetraose Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)OC2CO)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O LKOHREGGXUJGKC-UHFFFAOYSA-N 0.000 abstract 1
AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 abstract 1
SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 abstract 1
FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 abstract 1
LKOHREGGXUJGKC-GXSKDVPZSA-N alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-Glcp Chemical compound C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O LKOHREGGXUJGKC-GXSKDVPZSA-N 0.000 abstract 1
CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 abstract 1
DUKURNFHYQXCJG-JEOLMMCMSA-N alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)O[C@@H]1CO DUKURNFHYQXCJG-JEOLMMCMSA-N 0.000 abstract 1
AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 abstract 1
FKADDOYBRRMBPP-UHFFFAOYSA-N lacto-N-fucopentaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C2O)O)OC1CO FKADDOYBRRMBPP-UHFFFAOYSA-N 0.000 abstract 1
CMQZRJBJDCVIEY-UHFFFAOYSA-N lacto-N-fucopentaose III Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C1NC(C)=O CMQZRJBJDCVIEY-UHFFFAOYSA-N 0.000 abstract 1
IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 abstract 1
229940062780 lacto-n-neotetraose Drugs 0.000 abstract 1
RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Pediatric Medicine (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Dairy Products (AREA)
Jellies, Jams, And Syrups (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

DK98912118.1T 1997-03-31 1998-03-30 Ernæringssammensætninger indeholdende oligosaccharider DK0975235T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/829,157 US6045854A (en)	1997-03-31	1997-03-31	Nutritional formulations containing oligosaccharides
PCT/US1998/006216 WO1998043494A1 (en)	1997-03-31	1998-03-30	Nutritional formulations containing oligosaccharides

Publications (2)

Publication Number	Publication Date
DK0975235T3 true DK0975235T3 (da)	2006-10-02
DK0975235T4 DK0975235T4 (da)	2014-03-31

Family

ID=25253688

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98912118.1T DK0975235T4 (da)	1997-03-31	1998-03-30	Ernæringssammensætninger indeholdende oligosaccharider

Country Status (12)

Country	Link
US (2)	US6045854A (da)
EP (1)	EP0975235B2 (da)
JP (2)	JP4863236B2 (da)
AT (1)	ATE326862T1 (da)
CA (1)	CA2285065C (da)
DE (1)	DE69834633T3 (da)
DK (1)	DK0975235T4 (da)
ES (1)	ES2265161T5 (da)
MX (1)	MX210206B (da)
NO (1)	NO315682B1 (da)
PT (1)	PT975235E (da)
WO (1)	WO1998043494A1 (da)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19701382A1 (de) *	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
US6329170B1 (en) *	1999-04-23	2001-12-11	Northwest Hospital	Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof
DE19958985A1 (de) *	1999-12-07	2001-06-13	Nutricia Nv	Oligosaccharidmischung
EP1062873A1 (en) *	1999-12-13	2000-12-27	N.V. Nutricia	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
EP1372641A4 (en)	2001-03-05	2004-08-25	Stephen P Ernest	ENTERAL FORMULATION
DE10147100A1 (de) *	2001-09-25	2003-04-17	Numico Res B V	Antiinfektive Kohlenhydrate
DE10204000A1 (de) *	2002-02-01	2003-08-14	Nutricia Nv	Sialysierte Kohlenhydrate
DE60336063D1 (de) *	2002-05-31	2011-03-31	Childrens Hosp Medical Center	Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
US7977098B2 (en) *	2002-05-31	2011-07-12	Children's Hospital Medical Center	Antigenic binding patterns of norovirus to human histo-blood group antigens
DK1531832T3 (da) *	2002-06-28	2009-07-27	Glykos Finland Oy	Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré
EP1643862A1 (en) *	2003-06-24	2006-04-12	University of Kansas Medical Center	Infant formula
EP1689348B1 (en) *	2003-12-05	2013-05-15	Children's Hospital Medical Center	Oligosaccharide compositions and use thereof in the treatment of infection
ES1056525Y (es) *	2004-01-13	2004-07-16	Perez Alfredo Pineiro	Halador de tres rodillos para redes y aparejos de pesca.
ATE361101T1 (de) *	2004-08-24	2007-05-15	Nutricia Nv	Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
BRPI0707620A2 (pt)	2006-02-10	2011-05-10	Nestec Sa	mistura de oligossacarÍdeo
US20110152263A1 (en) *	2006-11-16	2011-06-23	Xi Jiang	Composition and method for inhibiting norovirus infection
US8197872B2 (en) *	2007-05-17	2012-06-12	The Regents Of The University Of California	Human milk oligosaccharides to promote growth of beneficial gut bacteria
JP5766947B2 (ja)	2007-09-07	2015-08-19	チルドレンズホスピタルメディカルセンター	臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
EP2060257A1 (en)	2007-11-08	2009-05-20	Nestec S.A.	Prevention and treatment of secondary infections following viral infection
SG185948A1 (en) *	2007-11-08	2012-12-28	Nestec Sa	Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2072052A1 (en) *	2007-12-17	2009-06-24	Nestec S.A.	Prevention of opportunistic infections in immune-compromised subjects
SG188887A1 (en) *	2008-03-14	2013-04-30	Nestec Sa	Synbiotic mixture
JP2012510476A (ja) *	2008-12-02	2012-05-10	プロラクタバイオサイエンス，インコーポレイテッド	ヒト乳透過組成物ならびにその製造および使用方法
US9103821B2 (en) *	2008-12-19	2015-08-11	Momenta Pharmaceuticals, Inc.	Methods related to modified glycans
EP2440582B1 (en)	2009-06-09	2018-11-07	Children's Hospital Medical Center	Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use
EP2451462B1 (en)	2009-07-06	2017-09-06	Children's Hospital Medical Center	Inhibiting inflammation with milk oligosaccharides
CN102497868A (zh) *	2009-07-15	2012-06-13	N.V.努特里奇亚	用于刺激免疫系统的不可消化低聚糖的混合物
WO2011136637A1 (en)	2010-04-27	2011-11-03	N.V. Nutricia	Use of human milk oligosaccharides in infant nutrition
CN106509916A (zh)	2010-04-27	2017-03-22	N·V·努特里奇亚	人乳寡糖在婴儿营养物中的用途
US8889637B2 (en)	2010-06-01	2014-11-18	Glycom A/S	Polymorphs of 2′-O-fucosyllactose and producing thereof
EP2465509A1 (en)	2010-11-23	2012-06-20	Nestec S.A.	Oligosaccharide composition for treating acute respiratory tract infections
EP2454948A1 (en) *	2010-11-23	2012-05-23	Nestec S.A.	Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP3338784B1 (en)	2010-12-31	2020-07-22	Abbott Laboratories	Human milk oligosaccharides for modulating inflammation
BR112013015951A2 (en)	2010-12-31	2018-07-10	Abbott Laboratories	nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof to treat and / or prevent enteric viral infection.
WO2012092157A2 (en)	2010-12-31	2012-07-05	Abbott Laboratories	Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
US11337990B2 (en) *	2010-12-31	2022-05-24	Abbott Laboratories	Human milk oligosaccharides to promote growth of beneficial bacteria
MY197622A (en)	2010-12-31	2023-06-28	Abbott Lab	Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MY180910A (en)	2010-12-31	2020-12-11	Abbott Lab	Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
ES2708924T3 (es)	2010-12-31	2019-04-12	Abbott Lab	Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias
SG191798A1 (en) *	2010-12-31	2013-08-30	Abbott Lab	Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
JP6129821B2 (ja)	2011-05-13	2017-05-17	グリコシンリミテッドライアビリティーカンパニー	プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
EP2522232A1 (en) *	2011-05-13	2012-11-14	Nestec S.A.	Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
EP2526784A1 (en)	2011-05-24	2012-11-28	Nestec S.A.	Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
DK2734210T3 (da) *	2011-07-22	2018-01-22	Abbott Lab	Galactooligosaccharider til forebyggelse af skade på og/eller fremme af heling af mave-tarm-kanalen
SG2014013478A (en) *	2011-08-29	2014-05-29	Abbott Lab	Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2943500B1 (en) *	2012-11-13	2017-11-08	Glycom A/S	Crystalline 3-o-fucosyllactose
US20150320780A1 (en) *	2012-12-14	2015-11-12	Glycom A/S	Mixture of fucosylate lactoses
EP2745705A1 (en) *	2012-12-18	2014-06-25	Abbott Laboratories	Nutritional use of human milk oligosaccharides
US10626460B2 (en)	2013-02-21	2020-04-21	Children's Hospital Medical Center	Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
EP2999358B1 (en)	2013-05-22	2021-07-07	Glycom A/S	Synthetic mixture of oligosaccharides for the treating a microbiota of a mammal
US9321803B2 (en)	2013-07-12	2016-04-26	Children's Hospital Medical Center	Compositions and methods for inhibiting norovirus infection
CN105722515A (zh)	2013-11-15	2016-06-29	雀巢产品技术援助有限公司	用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
CN113331426A (zh)	2014-04-08	2021-09-03	雅培公司	使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
WO2016046294A1 (en) *	2014-09-25	2016-03-31	Nestec S.A.	INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs)
WO2016063262A1 (en)	2014-10-24	2016-04-28	Glycom A/S	MIXTURES OF HMOs
BR112017007375A2 (pt)	2014-10-31	2017-12-19	Nestec Sa	composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral
CN107427054A (zh) *	2015-03-05	2017-12-01	雀巢产品技术援助有限公司	用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
CN107404925A (zh)	2015-03-05	2017-11-28	雀巢产品技术援助有限公司	用于预防或治疗婴儿或幼儿胃肠感染/炎症的组合物
WO2016176484A1 (en)	2015-04-28	2016-11-03	Children's Hospital Medical Center	Use of oligosaccharide compositions to enhance weight gain
WO2017021476A1 (en) *	2015-08-04	2017-02-09	Nestec S.A.	Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
EP3389668A4 (en)	2015-12-15	2019-08-21	Glycom A/S	MIXTURE OF HMOS
MX381980B (es) *	2016-01-26	2025-03-13	Soc Des Produits Nestle S A Star	Oligosacáridos de leche humana contra la acumulación de masa grasa excesiva y trastornos de la salud conexos más adelante en la vida.
WO2017129648A1 (en) *	2016-01-26	2017-08-03	Nestec S.A.	Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
AU2017326654C1 (en) *	2016-09-19	2022-07-21	Prolacta Bioscience, Inc.	Purified human milk oligosaccharides compositions
US20180103675A1 (en)	2016-10-14	2018-04-19	Mead Johnson Nutrition Company	Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) *	2016-12-12	2021-04-20	Mead Johnson Nutrition Company	Protein hydrolysates and methods of making same
EP3600397A4 (en)	2017-03-28	2021-01-27	Children's Hospital Medical Center	NOROVIRUS PARTICLE VACCINES AND THEIR MANUFACTURING AND USE PROCEDURES
MX2019011445A (es)	2017-05-24	2019-11-18	Nestle Sa	Composicion que comprende oligosacaridos de la leche humana (hmo) para usar en la mejora de la memoria a corto plazo y otros beneficios cognitivos.
US20200108084A1 (en)	2017-05-24	2020-04-09	Societe Des Produits Nestle S.A.	Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
US20200281245A1 (en)	2017-07-07	2020-09-10	Societe Des Products Nestle S.A	Human milk fortifier
US20200305488A1 (en) *	2017-07-07	2020-10-01	Societe Des Produitis Nestle S.A.	Human milk fortifier
US20200221749A1 (en)	2017-07-07	2020-07-16	Societe Des Produits Nestle S.A.	Human milk fortifier
US11197917B2 (en)	2017-12-01	2021-12-14	ByHeart, Inc.	Formulations for nutritional support in subjects in need thereof
PL3524067T3 (pl)	2018-02-08	2025-06-09	Chr. Hansen HMO GmbH	Suszona rozpyłowo mieszanina oligosacharydów mleka ludzkiego
WO2019160922A1 (en) *	2018-02-19	2019-08-22	Dupont Nutrition Biosciences Aps	Process for spray drying fucosyllactose solutions and related product compositions
EP3546060A1 (en) *	2018-03-27	2019-10-02	DuPont Nutrition Biosciences ApS	Process for spray drying fucosyllactose solutions and related product compositions
CN112218546B (zh)	2018-06-25	2024-05-24	雀巢产品有限公司	包含用于改善、增强、促进或调节中枢神经系统中gaba能功能的人乳低聚糖的组合物
AU2019296552B2 (en)	2018-06-25	2024-10-10	Societe Des Produits Nestle S.A.	Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
CN113226064A (zh) *	2018-12-20	2021-08-06	雀巢产品有限公司	人乳强化剂组合物
PH12021551924A1 (en) *	2019-03-05	2022-05-23	SociaTa Des Produits Nestla S A	A nutritional composition for use to enhance executive function
PH12021551814A1 (en) *	2019-06-04	2022-03-21	Nutricia Nv	NUTRITIONAL COMPOSITION COMPRISING 2âFUCOSYLLACTOSE AND 3âGALACTOSYLLACTOSE
WO2021015977A1 (en) *	2019-07-23	2021-01-28	Dupont Nutrition Biosciences Aps	Oral healthcare treatment and related compositions
ES1240969Y (es) *	2019-09-18	2020-07-30	Jennewein Biotechnologie Gmbh	Composiciones de cereales que contienen oligosacaridos de la leche humana
TW202126317A (zh)	2019-09-24	2021-07-16	美商普拉塔生技公司	用於治療發炎和免疫疾病之組成物和方法
GB2590375B (en) *	2019-12-11	2024-05-08	Mjn Us Holdings Llc	Staged nutritional compositions containing human milk oligosaccharides and uses thereof
TW202233201A (zh) *	2020-12-16	2022-09-01	荷蘭商弗里斯蘭康必奶荷蘭有限公司	包含ＬＮＦＰＩＩＩ和ＬＳＴａ的合成組成物
AU2022287240A1 (en)	2021-06-04	2023-12-07	N.V. Nutricia	Infant formula for feeding infants receiving infant formula and human breast milk

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5951264B2 (ja) *	1981-11-30	1984-12-13	雪印乳業株式会社	オリゴ糖含有粉末の製造方法
DD273543A3 (de) *	1987-09-14	1989-11-22	Univ Rostock	Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
SE462134B (sv) *	1987-10-22	1990-05-14	Biocarb Ab	Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning
ATE83611T1 (de) *	1988-07-07	1993-01-15	Milupa Ag	Verfahren zur enzymatischen herstellung von bifidogener saeuglings- und diaetnahrung.
US5095106A (en) *	1989-07-25	1992-03-10	Colgate-Palmolive	Olgiosaccharide inhibition of Streptococcus pyogenes adhesion
WO1991016449A1 (en) *	1990-04-16	1991-10-31	The Trustees Of The University Of Pennsylvania	Saccharide compositions, methods and apparatus for their synthesis
US5021245A (en) *	1990-05-22	1991-06-04	Abbott Laboratories	Infant formula containing a soy polysaccharide fiber source
WO1995002683A1 (en) *	1993-07-15	1995-01-26	Neose Pharmaceuticals	Method of synthesizing saccharide compositions
US5750176A (en) *	1994-03-09	1998-05-12	Abbott Laboratories	Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
JPH0838064A (ja) *	1994-07-26	1996-02-13	Meiji Seika Kaisha Ltd	有害細菌の感染を予防する飼料
US5545553A (en) *	1994-09-26	1996-08-13	The Rockefeller University	Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5827526A (en) *	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans

1997
- 1997-03-31 US US08/829,157 patent/US6045854A/en not_active Expired - Lifetime
1998
- 1998-03-30 JP JP54189298A patent/JP4863236B2/ja not_active Expired - Fee Related
- 1998-03-30 WO PCT/US1998/006216 patent/WO1998043494A1/en not_active Ceased
- 1998-03-30 DE DE69834633.5T patent/DE69834633T3/de not_active Expired - Lifetime
- 1998-03-30 PT PT98912118T patent/PT975235E/pt unknown
- 1998-03-30 DK DK98912118.1T patent/DK0975235T4/da active
- 1998-03-30 ES ES98912118.1T patent/ES2265161T5/es not_active Expired - Lifetime
- 1998-03-30 EP EP98912118.1A patent/EP0975235B2/en not_active Expired - Lifetime
- 1998-03-30 CA CA2285065A patent/CA2285065C/en not_active Expired - Lifetime
- 1998-03-30 AT AT98912118T patent/ATE326862T1/de active
- 1998-12-18 US US09/216,056 patent/US6146670A/en not_active Expired - Lifetime
1999
- 1999-09-23 NO NO19994621A patent/NO315682B1/no not_active IP Right Cessation
- 1999-09-29 MX MX9908953A patent/MX210206B/es unknown
2011
- 2011-09-07 JP JP2011195159A patent/JP2012036192A/ja active Pending

Also Published As

Publication number	Publication date
WO1998043494A1 (en)	1998-10-08
CA2285065C (en)	2011-07-19
JP2012036192A (ja)	2012-02-23
NO994621D0 (no)	1999-09-23
MX210206B (es)	2002-09-06
PT975235E (pt)	2006-10-31
EP0975235A1 (en)	2000-02-02
ATE326862T1 (de)	2006-06-15
ES2265161T5 (es)	2014-03-24
DK0975235T4 (da)	2014-03-31
NO994621L (no)	1999-09-23
US6146670A (en)	2000-11-14
ES2265161T3 (es)	2007-02-01
JP4863236B2 (ja)	2012-01-25
DE69834633T3 (de)	2014-05-08
MX9908953A (es)	2000-01-31
EP0975235B1 (en)	2006-05-24
EP0975235B2 (en)	2014-01-15
US6045854A (en)	2000-04-04
DE69834633D1 (de)	2006-06-29
CA2285065A1 (en)	1998-10-08
DE69834633T2 (de)	2007-05-03
NO315682B1 (no)	2003-10-13
JP2001517949A (ja)	2001-10-09

Publication	Publication Date	Title
DK0975235T3 (da)	2006-10-02	Ernæringssammensætninger indeholdende oligosaccharider
BG102425A (en)	1999-06-30	(methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
NO20001105L (no)	2000-05-05	Transgene pattedyr som danner oligosakkarider i melken
PE44895A1 (es)	1995-12-20	Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero
BR9611362A (pt)	2001-09-25	Composicões detergentes
IL118047A (en)	2000-11-21	Sulfated oligosaccharides pharmaceutical compositions containing them and preparation of sulfated hexopyranose homooligosaccharides
FI973828A0 (fi)	1997-09-29	Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
CA2339765A1 (en)	2000-02-17	Compounds and compositions for delivering active agents
YU23599A (sh)	2001-07-10	Stabilizovani antihistaminski sirup
EP0698031A4 (en)	1997-07-09	SIALYL LE x ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
BG102259A (en)	1998-09-30	Compostions with controlled paroxetine release
EP0783299A4 (en)	1999-06-30	COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
NO20092860L (no)	2000-01-28	2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
NZ333475A (en)	2000-04-28	Microemulsion all purpose liquid cleaning compositions containing 0.05% to 5.0% of an acaricidal agent
ZA966964B (en)	1997-02-19	Compositions having synergistic fungitonix effects.
AU571265B2 (en)	1988-04-14	Oxopyrimidine derivatives
PT1058544E (pt)	2005-04-29	Inibicao da actividade do tnf
EP1075796A4 (en)	2002-07-17	SWEETENER COMPOSITIONS
TR200002293T2 (tr)	2000-11-21	Farmasötik bileşimler.
ES2183346T3 (es)	2003-03-16	Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral.
ES2170377T3 (es)	2002-08-01	Composicion que contiene quitosana.
BG103779A (en)	2000-06-30	Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid
YU23498A (sh)	2001-12-26	Herbicidni 3,5-difluoropiridini
GB2314507A (en)	1998-01-07	Anti-emetic pharmaceutical compositions containing methotrimeprazine
CA2183745A1 (en)	1995-09-28	Detergent Compositions